Abstract
Background Understanding the associations of axial length (AL) with retinal thickness (RT) and choroidal thickness (CT) at different subgrids among diabetic participants are of great important in exploring potential protective mechanism and pathogenesis of diabetic retinopathy (DR) in myopic eyes. Therefore, this study aimed to investigate the associations of AL with RT and CT among participants with type-2 diabetes mellitus (T2DM).
Methods Participants with T2DM and registered with the government-monitored diabetes communities near Zhongshan Ophthalmic Center, Guangzhou, China, were consecutively invited to participate in the current study from October 2017 to April 2019. High-definition retina and choroid images of the macular area were obtained using swept-source optical coherence tomography.AL and other ocular biometrics were measured using Lenstar900. Linear regression models were used to assess relationships between AL and RT as well as CT.
Results A total of 1378 participants with a mean age of 63.8±7.75 years and mean AL of 23.6±1.15 mm were included in the current study. In the multivariate linear regression models, AL was positively associated with the central RT (β=4.11 per mm increased in AL, 95%confidence interval (CI)=2.66 to 5.56, P<0.001), but negatively associated with the RT of the outer ring (β=-3.37 per mm increased in AL, 95%CI=-4.19 to -2.56, P<0.001).Longer AL tended to have thinker CTs in the central (β=-27.4 per mm increased in AL, 95%CI=-31.2 to -23.7, P<0.001),outer ring (β=-20.8 per mm increased in AL, 95%CI=-23.8 to -17.7, P<0.001) and inner ring (β=-24.6 per mm increased in AL, 95%CI=-28.1 to -21.1, P<0.001).
Conclusions Myopic ocular elongation is accompanied by retinal thinning of the outer ring and retinal thickening of the foveal area. The CT of the macular area tended to become thinner with elongated AL among the diabetic subjects.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the Guangdong Province Science & Technology Plan (2014B020228002).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Institute Ethics Committee of ZOC (2017KYPJ094)
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵* Co-first author
Conflict of Interest: The authors have no financial or other conflicts of interest concerning this study.
Funding: This study was funded by the Guangdong Province Science & Technology Plan (2014B020228002).
Data Availability
The availability of all data referred to in the manuscript and note links below.
